Effect of the Energy of Consciousness (The Trivedi Effect®) on Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
Chemical and Biomolecular Engineering
Volume 2, Issue 2, June 2017, Pages: 113-123
Received: Feb. 7, 2017; Accepted: Feb. 18, 2017; Published: Mar. 6, 2017
Views 1148      Downloads 42
Authors
Mahendra Kumar Trivedi, Trivedi Global, Inc., Henderson, Nevada, USA
Alice Branton, Trivedi Global, Inc., Henderson, Nevada, USA
Dahryn Trivedi, Trivedi Global, Inc., Henderson, Nevada, USA
Gopal Nayak, Trivedi Global, Inc., Henderson, Nevada, USA
Michael Peter Ellis, Trivedi Global, Inc., Henderson, Nevada, USA
James Jeffery Peoples, Trivedi Global, Inc., Henderson, Nevada, USA
James Joseph Meuer, Trivedi Global, Inc., Henderson, Nevada, USA
Johanne Dodon, Trivedi Global, Inc., Henderson, Nevada, USA
John Lawrence Griffin, Trivedi Global, Inc., Henderson, Nevada, USA
John Suzuki, Trivedi Global, Inc., Henderson, Nevada, USA
Joseph Michael Foty, Trivedi Global, Inc., Henderson, Nevada, USA
Judy Weber, Trivedi Global, Inc., Henderson, Nevada, USA
Julia Grace McCammon, Trivedi Global, Inc., Henderson, Nevada, USA
Karen Brynes Allen, Trivedi Global, Inc., Henderson, Nevada, USA
Kathryn Regina Sweas, Trivedi Global, Inc., Henderson, Nevada, USA
Lezley Jo-Anne Wright, Trivedi Global, Inc., Henderson, Nevada, USA
Lisa A. Knoll, Trivedi Global, Inc., Henderson, Nevada, USA
Madeline E. Michaels, Trivedi Global, Inc., Henderson, Nevada, USA
Margaret Kweya Wahl, Trivedi Global, Inc., Henderson, Nevada, USA
Mark E. Stutheit, Trivedi Global, Inc., Henderson, Nevada, USA
Michelle Barnard, Trivedi Global, Inc., Henderson, Nevada, USA
Muriel Mae Ranger, Trivedi Global, Inc., Henderson, Nevada, USA
Paromvong Sinbandhit, Trivedi Global, Inc., Henderson, Nevada, USA
V. J. Kris Elig, Trivedi Global, Inc., Henderson, Nevada, USA
Kalyan Kumar Sethi, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Parthasarathi Panda, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Snehasis Jana, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Article Tools
Follow on us
Abstract
Magnesium gluconate is an organometallic pharmaceutical compound used for the prevention and treatment of hypomagnesemia. The objective of the current research work was to examine the influence of The Trivedi Effect®-Energy of Consciousness Healing Treatment (Biofield Energy Treatment) on magnesium gluconate for the alteration in the physicochemical, structural, thermal and behavioral properties using PXRD, PSD, FT-IR, UV-vis spectroscopy, TGA, and DSC analysis. Magnesium gluconate was divided into two parts – one part was control without any Biofield Energy Treatment, while another part was treated with The Trivedi Effect®-Energy of Consciousness Healing Treatment remotely by twenty renowned Biofield Energy Healers and defined as The Trivedi Effect® treated sample. The PXRD analysis exhibited that the crystallite size of the treated sample was remarkably altered from -63.63% to 80.14% compared with the control sample. The average crystallite size was significantly reduced by 22.14% in the treated sample compared with the control sample. The particle size values in the treated sample at d10 and d50 values were significantly decreased by 4.41% and 8.67% respectively, whereas at d90 value was increased by 3.99% compared to the control sample. The surface area analysis revealed that surface area of the treated sample was significantly increased by 5.21% compared with the control sample. The FT-IR and UV-vis analysis showed that structure of the magnesium gluconate remained identical in both the treated and control samples. The TGA analysis shown four steps thermal degradation of both the samples and the total weight loss of the treated sample was significantly decreased by 4.29% compared with the control sample. The melting temperature of the control and treated samples were 171.02°C and 170.93°C, respectively. The latent heat of fusion was significantly increased by 32.33% in the treated sample compared with the control sample. The TGA and DSC analysis indicated that the thermal stability of the treated sample was significantly improved compared with the control sample. The current study revealed that The Trivedi Effect®-Energy of Consciousness Healing Treatment might produce a new polymorphic form of magnesium gluconate, which could be more soluble and bioavailable along with improved thermal stability compared with the untreated compound. The treated sample could be more stable during manufacturing, delivery or storage conditions than the untreated sample. Hence, The Trivedi Effect® Treated magnesium gluconate would be very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic responses against inflammatory diseases, immunological disorders, stress, aging, and other chronic infections.
Keywords
Biofield Energy Healing Treatment, Consciousness Energy Healers, The Trivedi Effect®, Magnesium Gluconate, PXRD, Particle Size, Surface Area, TGA, DSC
To cite this article
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Michael Peter Ellis, James Jeffery Peoples, James Joseph Meuer, Johanne Dodon, John Lawrence Griffin, John Suzuki, Joseph Michael Foty, Judy Weber, Julia Grace McCammon, Karen Brynes Allen, Kathryn Regina Sweas, Lezley Jo-Anne Wright, Lisa A. Knoll, Madeline E. Michaels, Margaret Kweya Wahl, Mark E. Stutheit, Michelle Barnard, Muriel Mae Ranger, Paromvong Sinbandhit, V. J. Kris Elig, Kalyan Kumar Sethi, Parthasarathi Panda, Snehasis Jana, Effect of the Energy of Consciousness (The Trivedi Effect®) on Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate, Chemical and Biomolecular Engineering. Vol. 2, No. 2, 2017, pp. 113-123. doi: 10.11648/j.cbe.20170202.16
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Heaton FW (1990) Role of magnesium in enzyme systems in metal ions in biological systems, In: Sigel H, Sigel A (Eds.), Volume 26. Compendium on magnesium and its role in biology, nutrition and physiology, Marcel Dekker Inc., New York.
[2]
Frick DN, Banik S, Rypma RS (2007) Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: Magnesium provides a bridge for ATP to fuel unwinding. J Mol Biol 365: 1017-1032.
[3]
Garfinkel L, Garfinkel D (1985) Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 4: 60-72.
[4]
Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol JC, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18: 215-223.
[5]
Fleming TE, Mansmann Jr HC (1999) Methods and compositions for the prevention and treatment of diabetes mellitus. United States Patent 5871769, 1-10.
[6]
Fleming TE, Mansmann Jr HC (1999) Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections. United States Patent 5939394, 1-11.
[7]
Guerrera MP, Volpe SL, Mao JJ (2009) Therapeutic uses of magnesium. Am Fam Physician 80: 157-162.
[8]
Gums JG (2004) Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61: 1569-1576.
[9]
Gröber U, Schmidt J, Kisters K (2015) Magnesium in prevention and therapy. Nutrients 7: 8199-8226.
[10]
Clague JE, Edwards RH, Jackson MJ (1992) Intravenous magnesium loading in chronic fatigue syndrome. Lancet 340: 124-125.
[11]
Weglicki WB (2000) Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution. United States Patent 6100297, 1-6.
[12]
Martin RW, Martin JN Jr, Pryor JA, Gaddy DK, Wiser WL, Morrison JC (1988) Comparison of oral ritodrine and magnesium gluconate for ambulatory tocolysis. Am J Obstet Gynecol 158: 1440-1445.
[13]
Turner RJ, Dasilva KW, O'Connor C, van den Heuvel C, Vink R (2004) Magnesium gluconate offers no more protection than magnesium sulphate following diffuse trau-matic braininjury in rats. J Am Coll Nutr 23: 541S-544S.
[14]
Lee KH, Chung SH, Song JH, Yoon JS, Lee J, Jung MJ, Kim JH (2013) Cosmetic compositions for skin-tightening and method of skin-tightening using the same. United States Patent 8580741 B2.
[15]
Stenger VJ (1999) Bioenergetic fields. Sci Rev Alternative Med 3.
[16]
Warber SL, Cornelio D, Straughn J, Kile G (2004) Biofield energy healing from the inside. J Altern Complement Med 10: 1107-1113.
[17]
Rubik B (2002) The biofield hypothesis: Its biophysical basis and role in medicine. J Altern Complement Med 8: 703-717.
[18]
Koithan M (2009) Introducing complementary and alternative therapies. J Nurse Pract 5: 18-20.
[19]
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana S (2015) Characterization of physicochemical and spectroscopic properties of biofield energy treated bio peptone. Advances in Bioscience and Bioengineering 3. 59-66.
[20]
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana S (2015) Physicochemical and spectroscopic characterization of yeast extract powder after the biofield energy treatment. American Journal of Life Sciences 3: 387-394.
[21]
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2015) Antibiogram, biochemical reactions, and genotypic pattern of biofield treated Pseudomonas aeruginosa. J Trop Dis 4: 181
[22]
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) Evaluation of antibiogram, genotype and phylogenetic analysis of biofield treated Nocardia otitidis. Biol Syst Open Access 4: 143.
[23]
Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. J Integr Oncol 4. 141.
[24]
Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) Antimicrobial susceptibility pattern and biochemical characteristics of Staphylococcus aureus: Impact of biofield treatment. J Microb Biochem Technol 7. 238-241.
[25]
Trivedi MK, Patil S, Harish S, Gangwar M, Jana S (2015) Biofield Treatment: An alternative approach to combat multidrug-resistant susceptibility pattern of Raoultella ornithinolytica. Altern Integr Med 4: 193.
[26]
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) In vitro evaluation of biofield treatment on viral load against human immunodeficiency-1 and cytomegalo viruses. American Journal of Health Research 3: 338-343.
[27]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Latiyal O, Jana S (2015) Characterization of physical, thermal and structural properties of chromium (VI) oxide powder: Impact of biofield treatment. J Powder Metall Min 4: 128.
[28]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Latiyal O, Jana S (2015) Potential impact of biofield energy treatment on the atomic, physical and thermal properties indium powder. J Material Sci Eng 4. 198.
[29]
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) Impact of biofield energy treatment on soil fertility. Earth Sciences 4: 275-279.
[30]
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2015) Agronomic characteristics, growth analysis, and yield response of biofield treated mustard, cowpea, horse gram, and groundnuts. International Journal of Genetics and Genomics 3: 74-80.
[31]
Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Spectroscopic characterization of chloramphenicol and tetracycline: An impact of biofield. Pharm Anal Acta 6. 395.
[32]
Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Spectroscopic characterization of biofield treated metronidazole and tinidazole. Med chem 5: 340-344.
[33]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Latiyal O, Jana S (2015) Physical, atomic and thermal properties of biofield treated lithium powder. J Adv Chem Eng 5. 136.
[34]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Mishra RK, Jana S (2015) Biofield treatment: A potential strategy for modification of physical and thermal properties of gluten hydrolysate and ipomoea macroelements. J Nutr Food Sci 5. 414.
[35]
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana S (2015) Physicochemical and spectroscopic characterization of p-chlorobenzaldehyde: an impact of biofield energy treatment. Insights in Analytical Electrochemistry 1: 5.
[36]
Trivedi MK, Branton A, Trivedi D, Nayak G, Latiyal O, Jana S (2015) Evaluation of biofield treatment on atomic and thermal properties of ethanol. Organic Chem Curr Res 4: 145.
[37]
Ranade VV, Somberg JC (2001) Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8. 345-357.
[38]
Chereson R (2009) Bioavailability, bioequivalence, and drug selection. In: Makoid CM, Vuchetich PJ, Banakar UV (eds) Basic pharmacokinetics (1st Edn) Pharmaceutical Press, London.
[39]
Blagden N, de Matas M, Gavan PT, York P (2007) Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59: 617-630.
[40]
Trivedi MK, Mohan TRR (2016) Biofield energy signals, energy transmission and neutrinos. American Journal of Modern Physics 5: 172-176.
[41]
Chauhan A, Chauhan P (2014) Powder XRD technique and its applications in science and technology. J Anal Bioanal Tech 5: 212.
[42]
Alexander L, Klug HP (1950) Determination of crystallite size with the X-Ray spectrometer. J App Phys 21: 137.
[43]
Langford JI, Wilson AJC (1978) Scherrer after sixty years: A survey and some new results in the determination of crystallite size. J Appl Cryst 11: 102-113.
[44]
Inoue M, Hirasawa I (2013) The relationship between crystal morphology and XRD peak intensity on CaSO4.2H2O. J Crystal Growth 380: 169-175.
[45]
Raza K, Kumar P, Ratan S, Malik R, Arora S (2014) Polymorphism: The phenomenon affecting the performance of drugs. SOJ Pharm Pharm Sci 1. 10.
[46]
Brittain HG (2009) Polymorphism in pharmaceutical solids in Drugs and Pharmaceutical Sciences, volume 192, 2nd Edn, Informa Healthcare USA, Inc., New York.
[47]
Murray HH, Lyons SC (1960) Further correlation of kaolinite crystallinity with chemical and physical properties. Clays Clay Miner 8. 11-17.
[48]
Sun J, Wang F, Sui Y, She Z, Zhai W, Wang C, Deng Y (2012) Effect of particle size on solubility, dissolution rate, and oral bioavailability: Evaluation using coenzyme Q10 as naked nanocrystals. Int J Nanomed 7: 5733-5744.
[49]
Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J (2014) Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9. 304-316.
[50]
Buckton G, Beezer AE (1992) The relationship between particle size and solubility. Int J Pharmaceutics 82: R7-R10.
[51]
Nikolic VD, Illic DP, Nikolic LB, Stanojevic LP, Cakic MD, Tacic AD, Ilic-Stojanovic SS (2014) The synthesis and characterization of iron (II) gluconate. Advanced Technologies 3: 16-24.
[52]
Ji L, Yin W, Fu-Jia M (2004) Confirmation of the chemical structure of magnesium gluconate. Pharmaceutical Care and Research 4: 272-273.
[53]
Hesse M, Meier H, Zeeh B (1997) Spectroscopic methods in organic chemistry, Georg Thieme Verlag Stuttgart, New York.
[54]
Alves R, Reis TVS, Silva LCC, Storpírtis S, Mercuri LP, Matos JR (2010) Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions. Braz J Pharm Sci 46. 343-351.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186